The authors present a clinical report focused on the overlap between myocarditis and genetic cardiomyopathies of the dilated and arrhythmogenic spectrum. Our cohort was composed of 25 patients undergoing extensive baseline characterization and prospective reassessment by a dedicated multidisciplinary disease unit during a median follow-up of 69 months. We showed that the use of multimodal imaging allowed both discrimination of specific genotypes and identification of myocardial inflammation proven using endomyocardial biopsy. In addition, we showed that the use of immunomodulatory therapy was beneficial for most patients. (c) 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report / Peretto, Giovanni; De Luca, Giacomo; Villatore, Andrea; Di Resta, Chiara; Sala, Simone; Palmisano, Anna; Vignale, Davide; Campochiaro, Corrado; Lazzeroni, Davide; De Gaspari, Monica; Rizzo, Stefania; Busnardo, Elena; Ferro, Paola; Gianolli, Luigi; Basso, Cristina; Dagna, Lorenzo; Esposito, Antonio; Benedetti, Sara; Della Bella, Paolo. - In: JACC. BASIC TO TRANSLATIONAL SCIENCE. - ISSN 2452-302X. - 8:7(2023), pp. 755-765. [10.1016/j.jacbts.2023.02.018]
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report
Peretto, Giovanni
Primo
;De Luca, GiacomoSecondo
;Villatore, Andrea;Di Resta, Chiara;Palmisano, Anna;Vignale, Davide;Campochiaro, Corrado;Dagna, Lorenzo;Esposito, Antonio;
2023-01-01
Abstract
The authors present a clinical report focused on the overlap between myocarditis and genetic cardiomyopathies of the dilated and arrhythmogenic spectrum. Our cohort was composed of 25 patients undergoing extensive baseline characterization and prospective reassessment by a dedicated multidisciplinary disease unit during a median follow-up of 69 months. We showed that the use of multimodal imaging allowed both discrimination of specific genotypes and identification of myocardial inflammation proven using endomyocardial biopsy. In addition, we showed that the use of immunomodulatory therapy was beneficial for most patients. (c) 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S2452302X23001237-main.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
1.78 MB
Formato
Adobe PDF
|
1.78 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
